Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Plos One|July 9, 2011
The blood of healthy individuals exhibits CD8 T cells with a highly altered TCR Vb repertoire but with an unmodified phenotypeNicolas Degauque, Françoise Boeffard, Yohann Foucher, et al.Drug Discovery Today|November 2, 2020
Tetraspanins: useful multifunction proteins for the possible design and development of small-molecule therapeutic toolsJean-Michel H Robert, Nathalie Gisèle Amoussou, Hubert Le Mai, et al.Expert Review of Clinical Immunology|May 19, 2010
Chronic rejection of human kidney allograftsCaroline Ballet, Magali Giral, Joanna Ashton-Chess, et al.Kidney International|September 6, 2020
Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and deathAmaury Dujardin, Marine Lorent, Yohann Foucher, et al.Clinical Kidney Journal|April 12, 2024
Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipientsTess Van Meerhaeghe, Naoka Murakami, Alain Le Moine, et al.Molecular Immunology|August 26, 2006
Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biasesPatrick Miqueu, Marina Guillet, Nicolas Degauque, et al.Journal of Neuroinflammation|July 5, 2015
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammationFlora Guillot, Alexandra Garcia, Marion Salou, et al.Frontiers in Immunology|April 14, 2022
Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft OutcomesMargaux Pacaud, Luc Colas, Clarisse Kerleau, et al.Frontiers in Immunology|December 15, 2022
Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patientsChristophe Masset, Jacques Dantal, Jean-Paul Soulillou, et al.European Journal of Immunology|September 8, 2025
Extracellular Vesicles in Lung Transplantation: Biomarkers, Pathophysiological Players, and Therapeutic Weapons?Valentin Mandin, Amandine Dupuy, Adrien Tissot, et al.Pageof 22